Recently, PGE2 has been implicated in the enhancement of protumorigenic Th2-type cytokine, such as IL-4, IL-5, and IL-10, and inhibition of the anti-tumor Th1 cytokine production, such as IFN-γ and IL-2 [67, 68]. Here, IL10 is linked to neoplasm.